ANI Pharmaceuticals, Inc. (ANIP)

ANI Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,304	1,127	703	588	359	746
Market Cap Growth	109.59%	60.39%	19.57%	63.73%	-51.87%	39.68%
Enterprise Value	1,351	1,191	936	775	532	864
PE Ratio	39.36	65.69	-14.19	-13.73	-15.92	122.36
PS Ratio	2.52	2.32	2.22	2.72	1.72	3.61
PB Ratio	2.88	2.60	2.24	1.76	1.83	3.50
P/FCF Ratio	11.03	10.24	-17.86	172.11	39.30	19.12
P/OCF Ratio	11.26	9.47	-22.52	176.88	23.51	16.34
EV/Sales Ratio	2.61	2.45	2.96	3.58	2.55	4.18
EV/EBITDA Ratio	10.53	11.05	37.38	248.61	18.90	14.23
EV/EBIT Ratio	20.20	25.45	-27.04	-17.55	-32.21	53.59
EV/FCF Ratio	11.43	10.82	-23.80	226.91	58.22	22.16
Debt / Equity Ratio	0.63	0.66	0.91	0.86	0.95	0.87
Debt / EBITDA Ratio	2.22	2.65	11.44	92.22	6.60	3.06
Debt / FCF Ratio	2.41	2.59	-7.29	84.17	20.33	4.76
Quick Ratio	3.00	2.63	2.20	2.61	1.38	2.26
Current Ratio	3.95	3.57	3.46	3.68	2.17	3.04
Asset Turnover	0.58	0.57	0.42	0.40	0.45	0.46
Interest Coverage	2.81	1.74	-1.23	-3.70	-1.75	1.24
Return on Equity (ROE)	7.90%	4.30%	-15.70%	-18.60%	-11.50%	2.90%
Return on Assets (ROA)	3.80%	2.00%	-6.60%	-7.80%	-4.80%	1.40%
Return on Capital (ROIC)	6.48%	6.35%	-5.14%	-7.02%	-4.33%	7.81%
Earnings Yield	2.60%	1.52%	-7.05%	-7.28%	-6.28%	0.82%
FCF Yield	9.07%	9.77%	-5.60%	0.58%	2.54%	5.23%
Buyback Yield / Dilution	-17.49%	-11.89%	-29.09%	-5.28%	0.63%	-2.28%
Total Shareholder Return	-17.49%	-11.89%	-29.09%	-5.28%	0.63%	-2.28%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).